Max Robotics — Global Service Robot Directory + US Certification

About

Sameer Siddiqui is a pioneering urologic surgeon and researcher whose work has fundamentally advanced the field of robotic oncologic surgery. His research focuses on optimizing surgical outcomes for prostate and kidney cancers, with a particular emphasis on refining robotic techniques to manage complex patient histories and high-risk disease. His landmark study, “Biochemical Recurrence Following Robot-Assisted Radical Prostatectomy: Analysis of 1384 Patients with a Median 5-year Follow-up” (193 citations), provided critical long-term oncologic data that helped validate the efficacy of the robotic approach. Dr. Siddiqui has also made seminal contributions to nephron-sparing surgery, demonstrating in his highly cited work “Robotic Partial Nephrectomy for Renal Tumors Larger Than 4cm” (147 citations) that robotic techniques can be safely applied to larger, more challenging tumors. A hallmark of his research is addressing surgical complications and patient-specific risk factors, as seen in his studies on rectal injury management and the impact of prior abdominal or inguinal surgery on robotic outcomes. His early work on high-grade prostate cancer (Gleason 8-9) provided crucial insights into biochemical recurrence predictors. With a career dedicated to pushing the boundaries of minimally invasive urologic oncology, Dr. Siddiqui’s research remains essential reading for surgeons seeking to improve patient outcomes through evidence-based robotic practice.